The "Graft Versus Host Disease (GVHD) - Global Clinical Trials Review, 2024" report has been added to ResearchAndMarkets.com's offering.This report will provide valuable data on the state of clinical ...

A feasibility study on the use of a mobile application for patients after undergoing a stem cell transplant may help care ...

There are a number of unmet needs for patients with GvHD, especially those with steroid-refractory GvHD. These are patients who are resistant or develop resistance, to corticosteroid treatment.

Right after a bone marrow transplant, patients confront the likelihood of graft-versus-host-disease (GVHD), in the blessed ...

transfusion-associated graft-versus-host disease (TA-GVHD), post-transfusion purpura (PTP) and anaphylactic reactions because of IgA in plasma transfused to IgA-deficient recipients with anti-IgA ...

Considering taking a vitamin or supplement to treat Graft-Versus-Host+Disease+(Gvhd)? Below is a list of common natural remedies used to treat or reduce the symptoms of Graft-Versus-Host+Disease+ ...

SER-155 is also designed to induce immune tolerance responses to reduce the incidence of GvHD. “We are pleased to complete enrollment in Cohort 2 of our SER-155 Phase 1b study and are looking ...

Patients need these immunosuppressive medicines in order to help prevent graft-versus-host disease (GVHD). After the infusion, the child will be watched very closely to make sure the new stem cells ...

However, pre-HSCT myeloablation and graft-versus-host disease (GVHD) prophylaxis agents have toxic effects and could eradicate residual CAR T cells and compromise antitumor effects. Whether the ...

Incyte Corporation INCY reported first-quarter 2024 adjusted earnings of 64 cents per share, which missed the Zacks Consensus ...

In the first quarter, Jakafi net product revenue of $572 million does not fully reflect the demand growth as total patients ...